BROADWOOD CAPITAL INC - Q3 2022 holdings

$1.31 Billion is the total value of BROADWOOD CAPITAL INC's 8 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .

 Value Shares↓ Weighting
STAA  STAAR SURGICAL CO$606,166,000
-0.5%
8,592,0070.0%46.26%
+0.7%
MNST  MONSTER BEVERAGE CORP NEW$404,928,000
-6.2%
4,656,4880.0%30.90%
-5.0%
IWM  ISHARES TRrussell 2000 etf$113,795,000
-2.6%
690,0000.0%8.68%
-1.4%
AXON  AXON ENTERPRISE INC$87,977,000
+24.2%
760,0620.0%6.72%
+25.8%
LCTX  LINEAGE CELL THERAPEUTICS IN$39,477,000
-28.5%
34,935,4850.0%3.01%
-27.6%
BTRS BuyBTRS HOLDINGS INC$39,167,000
+97.7%
4,229,652
+6.3%
2.99%
+100.2%
OCX  ONCOCYTE CORP$17,048,000
-18.9%
23,353,6970.0%1.30%
-17.9%
AGE  AGEX THERAPEUTICS INC$1,683,000
-2.5%
2,997,1560.0%0.13%
-1.5%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STAAR SURGICAL CO42Q3 202359.1%
MONSTER BEVERAGE CORP NEW34Q3 202349.7%
ISHARES TR33Q3 202314.8%
ONCOCYTE CORPORATION31Q2 20234.6%
BIOTIME INC25Q2 201917.8%
AXON ENTERPRISE INC24Q3 202313.4%
AGEX THERAPEUTICS INC20Q3 20231.5%
LINEAGE CELL THERAPEUTICS INC17Q3 20235.1%
ASTERIAS BIOTHERAPEUTICS INC16Q4 20182.9%
CYNOSURE INC15Q4 201610.4%

View BROADWOOD CAPITAL INC's complete holdings history.

Latest filings
TypeFiled
42024-04-15
13F-HR2024-02-14
42024-02-08
42024-01-10
42024-01-05
42023-11-30
13F-HR2023-11-14
42023-11-14
42023-11-09
42023-11-06

View BROADWOOD CAPITAL INC's complete filings history.

Compare quarters

Export BROADWOOD CAPITAL INC's holdings